These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6932833

  • 1. Prazosin in the treatment of severe chronic congestive cardiac failure.
    Hockings BE, Cope GD, Clarke GM, Taylor RR.
    Aust N Z J Med; 1980 Aug; 10(4):420-5. PubMed ID: 6932833
    [Abstract] [Full Text] [Related]

  • 2. Acute and chronic haemodynamic effects of prazosin in left ventricular failure.
    Stein L, Foster PR, Friedman AW, Statza J, McHenry PL.
    Br Heart J; 1981 Feb; 45(2):186-92. PubMed ID: 7459177
    [Abstract] [Full Text] [Related]

  • 3. Acute hemodynamic and long-term clinical effects of prazosin in the treatment of chronic congestive heart failure.
    von der Lippe G, Ohm OJ, Lund-Johansen P.
    Acta Med Scand; 1981 Feb; 210(3):213-6. PubMed ID: 7293839
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA, Miller RR, DeMaria AN, Maxwell KS, Neumann A, Mason DT.
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [Abstract] [Full Text] [Related]

  • 5. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW, Claxton H, Middlebrook K, Anderson S, Pitt A.
    Med J Aust; 1980 Jul 26; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract] [Full Text] [Related]

  • 6. Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system.
    Yui Y, Sakurai T, Nakajima H, Kawai C.
    Jpn Circ J; 1984 Apr 26; 48(4):365-72. PubMed ID: 6371282
    [Abstract] [Full Text] [Related]

  • 7. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
    Bertel O, Burkart F, Bühler FR.
    Am Heart J; 1981 May 26; 101(5):529-33. PubMed ID: 7223592
    [Abstract] [Full Text] [Related]

  • 8. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB, Williams RL, Ports TA, Baughman RA, Benet LZ, Parmley WW, Chatterjee K.
    Ann Intern Med; 1979 Sep 26; 91(3):345-9. PubMed ID: 475164
    [Abstract] [Full Text] [Related]

  • 9. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
    Feldman RC, Ball RM, Winchester MA, Jaillon P, Kates RE, Harrison DC.
    Am Heart J; 1981 May 26; 101(5):534-40. PubMed ID: 7223593
    [Abstract] [Full Text] [Related]

  • 10. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE, Magorien RD, Triffon DW, Blanford MF, Unverferth DV, Leier CV.
    Am J Cardiol; 1979 Nov 26; 44(6):1178-82. PubMed ID: 495512
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA, Needham KE, Evenson MK, Amsterdam EE, Mason DT.
    Am J Med; 1981 Jul 26; 71(1):153-60. PubMed ID: 7246573
    [Abstract] [Full Text] [Related]

  • 12. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
    Sparvieri F, Cesari GP, Soro A.
    G Ital Cardiol; 1980 Jul 26; 10(6):730-40. PubMed ID: 6780400
    [Abstract] [Full Text] [Related]

  • 13. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
    Chatterjee K, Ports TA, Arnold S, Brundage B, Parmley W.
    Br Heart J; 1979 Dec 26; 42(6):657-63. PubMed ID: 534582
    [Abstract] [Full Text] [Related]

  • 14. Haemodynamic effects of a single low dose of prazosin in patients with chronic congestive cardiac failure correlations with pharmacokinetics.
    Horowitz JD, Dynon MK, Jarrott B, Brennan JB, Oliver LE, Goble AJ, Louis WJ.
    Clin Exp Pharmacol Physiol; 1984 Dec 26; 11(1):7-15. PubMed ID: 6713738
    [Abstract] [Full Text] [Related]

  • 15. The pharmacokinetic, pharmacodynamic and haemodynamic effects of acute and chronic alpha-adrenoceptor blockade in chronic heart failure.
    Taylor SH, Silke B.
    Ann Acad Med Singap; 1981 Oct 26; 10(4 Suppl):45-51. PubMed ID: 6124209
    [Abstract] [Full Text] [Related]

  • 16. [Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year].
    Reifart N, Schmidt-Moritz AD, Nadj M, Kaltenbach M, Bussmann WD.
    Z Kardiol; 1985 Apr 26; 74(4):205-12. PubMed ID: 3923726
    [Abstract] [Full Text] [Related]

  • 17. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin.
    Awan NA, Beattie JM, Evenson ME, Needham KE, Mason DT.
    J Cardiovasc Pharmacol; 1982 Apr 26; 4 Suppl 1():S176-80. PubMed ID: 6175836
    [Abstract] [Full Text] [Related]

  • 18. [Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
    Wirtzfeld A, Klein G, Himmler FC, Schmidt G, Kutschera I, Sauer E.
    Dtsch Med Wochenschr; 1980 Oct 03; 105(40):1379-83. PubMed ID: 7449633
    [Abstract] [Full Text] [Related]

  • 19. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H, Sassa H, Oba M, Fukaya T, Okubo M, Niwa T, Matsui E.
    Jpn Heart J; 1980 Nov 03; 21(6):827-36. PubMed ID: 7007686
    [Abstract] [Full Text] [Related]

  • 20. Haemodynamic effects of prazosin in CHF.
    Reuben SR, Kuan P, Gale EV, Wilde PM.
    Acta Med Scand Suppl; 1981 Nov 03; 652():145-8. PubMed ID: 6949460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.